BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28918747)

  • 1. Omega-3 Polyunsaturated Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance Dexamethasone Sensitivity in Multiple Myeloma Cells by the p53/miR-34a/Bcl-2 Axis.
    Dai X; Li M; Geng F
    Biochemistry (Mosc); 2017 Jul; 82(7):826-833. PubMed ID: 28918747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
    Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
    Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression.
    Murray MY; Rushworth SA; Zaitseva L; Bowles KM; Macewan DJ
    Cell Cycle; 2013 Jul; 12(13):2144-53. PubMed ID: 23759586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells.
    Abdi J; Garssen J; Faber J; Redegeld FA
    J Nutr Biochem; 2014 Dec; 25(12):1254-62. PubMed ID: 25277647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant presenilin2 promotes apoptosis through the p53/miR-34a axis in neuronal cells.
    Li LH; Tu QY; Deng XH; Xia J; Hou DR; Guo K; Zi XH
    Brain Res; 2017 May; 1662():57-64. PubMed ID: 28189560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
    Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a upregulation during seizure-induced neuronal death.
    Sano T; Reynolds JP; Jimenez-Mateos EM; Matsushima S; Taki W; Henshall DC
    Cell Death Dis; 2012 Mar; 3(3):e287. PubMed ID: 22436728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
    Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
    Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a and bcl-2 expression in whitefish (Coregonus lavaretus) after microcystin-LR exposure.
    Łakomiak A; Brzuzan P; Jakimiuk E; Florczyk M; Woźny M
    Comp Biochem Physiol B Biochem Mol Biol; 2016 Mar; 193():47-56. PubMed ID: 26691544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of stable multiple myeloma cell line with overexpressed PDCD5 and its proapoptosis mechanism.
    Feng W; Fu Y; Zhang Y; Lv B; Li X; Zhang F; Gui R; Liu J
    Int J Clin Exp Pathol; 2015; 8(9):10635-43. PubMed ID: 26617773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.
    Song C; Lu P; Sun G; Yang L; Wang Z; Wang Z
    Biochem Biophys Res Commun; 2017 Jan; 482(1):22-27. PubMed ID: 27836543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGCG enhances cancer cells sensitivity under
    Kang Q; Zhang X; Cao N; Chen C; Yi J; Hao L; Ji Y; Liu X; Lu J
    Food Chem Toxicol; 2019 Nov; 133():110807. PubMed ID: 31494133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
    Herbert KJ; Cook AL; Snow ET
    Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.
    Yan S; Wang M; Zhao J; Zhang H; Zhou C; Jin L; Zhang Y; Qiu X; Ma B; Fan Q
    Int J Mol Med; 2016 Jul; 38(1):201-9. PubMed ID: 27247228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Bcl-2 expression by miR-34a mediates palmitate-induced Min6 cells apoptosis.
    Lin X; Guan H; Huang Z; Liu J; Li H; Wei G; Cao X; Li Y
    J Diabetes Res; 2014; 2014():258695. PubMed ID: 24829923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
    Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
    Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.